Search research articles
Contact Us
Filters
Showing results (1251-1260 of 3,827) with videos related to
Page
of 383
Sort By:
Cancer Cell
|
July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
Cancer Cell
|
July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance
Daniël A Lionarons, David C Hancock, Sareena Rana, et al.
Cancer Cell
|
October 16, 2019
Venetoclax in Lymphoid Malignancies: New Insights, More to Learn
Rachel Thijssen, Andrew W Roberts
Cancer Cell
|
October 16, 2019
PRC2 Plays Red Light, Green Light with MHC-I and CD8<sup>+</sup> T Cells
Johnathan R Whetstine
Cancer Cell
|
September 4, 2018
Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Niraj Shenoy, Edward Creagan, Thomas Witzig, et al.
Cancer Cell
|
September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Tenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Cancer Cell
|
September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
Shunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Cancer Cell
|
September 12, 2018
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
Allison L Boyd, Lili Aslostovar, Jennifer Reid, et al.
Cancer Cell
|
July 24, 2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Lingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Cancer Cell
|
September 14, 2016
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement
Rony Dahan, Jeffrey V Ravetch
Page
of 383
Search research articles
Search
Showing results (1251-1260 of 3,827) with videos related to
Sort By:
Page
of 383
Cancer Cell
|
July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
Cancer Cell
|
July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance
Daniël A Lionarons, David C Hancock, Sareena Rana, et al.
Cancer Cell
|
October 16, 2019
Venetoclax in Lymphoid Malignancies: New Insights, More to Learn
Rachel Thijssen, Andrew W Roberts
Cancer Cell
|
October 16, 2019
PRC2 Plays Red Light, Green Light with MHC-I and CD8<sup>+</sup> T Cells
Johnathan R Whetstine
Cancer Cell
|
September 4, 2018
Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Niraj Shenoy, Edward Creagan, Thomas Witzig, et al.
Cancer Cell
|
September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Tenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Cancer Cell
|
September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
Shunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Cancer Cell
|
September 12, 2018
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
Allison L Boyd, Lili Aslostovar, Jennifer Reid, et al.
Cancer Cell
|
July 24, 2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Lingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Cancer Cell
|
September 14, 2016
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement
Rony Dahan, Jeffrey V Ravetch
Page
of 383